| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 36.244 | 117.023 | 96.727 | 142.284 | 169.793 | 236.323 |
| Total Income - EUR | - | - | - | - | 37.710 | 122.522 | 102.104 | 147.677 | 175.223 | 243.011 |
| Total Expenses - EUR | - | - | - | - | 6.652 | 20.315 | 19.021 | 72.029 | 59.149 | 67.721 |
| Gross Profit/Loss - EUR | - | - | - | - | 31.058 | 102.207 | 83.083 | 75.648 | 116.074 | 175.290 |
| Net Profit/Loss - EUR | - | - | - | - | 30.695 | 101.104 | 80.956 | 72.993 | 114.769 | 169.264 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr.preda Iclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 69.139 | 111.179 | 100.090 | 90.608 | 326.881 | 309.201 |
| Current Assets | - | - | - | - | 40.354 | 49.252 | 71.073 | 18.958 | 125.260 | 354.996 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 21.388 | 10.455 | 2.069 | 0 | 2.456 | 2.062 |
| Cash | - | - | - | - | 18.966 | 38.797 | 69.004 | 18.958 | 122.804 | 352.934 |
| Shareholders Funds | - | - | - | - | 30.737 | 131.258 | 146.637 | 73.033 | 187.581 | 169.304 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 45.490 | 2.201 | 3.529 | 20.864 | 254.316 | 491.390 |
| Income in Advance | - | - | - | - | 33.267 | 26.972 | 20.997 | 15.669 | 10.244 | 3.503 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr.preda Iclinic S.r.l.